# Pharmacokinetics of Tacrolimus in Liver Transplantation Patients Treated With Prograf and Modified Release Tacrolimus

> **NCT00909571** · PHASE3 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 10 (actual)

## Conditions studied

- Liver Transplantation

## Interventions

- **DRUG:** FK506E (modified release tacrolimus)
- **DRUG:** Prograf (tacrolimus)

## Key facts

- **NCT ID:** NCT00909571
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2010-04-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00909571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00909571, "Pharmacokinetics of Tacrolimus in Liver Transplantation Patients Treated With Prograf and Modified Release Tacrolimus". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00909571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*